1. Arias CA, Murray BE. The rise of the enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266–78.
2. Center for Disease Control and Prevention. Antibiotic Resistance Threats in the United States 2019. In: Atlanta, GA: National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention; 2019: http://www.cdc.gov/drugresistance/Biggest-Threats.html. Accessed 1 March 2020.This is the most recent report on the state of multidrug resistance pathogens in the US.
3. Centers for Disease Control and Prevention. US Department of Health and Human Services and the Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States 2013. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Published 2013. Accessed July 24, 2015.
4. Ford CD, Gazdik MA, Lopansri BK, Webb B, Mitchell B, Coombs J, et al. Vancomycin-resistant enterococcus colonization and bacteremia and hematopoietic stem cell transplantation outcomes. Biol Blood Marrow Transplant. 2017;23(2):340–6.
5. Weber S, Hogardt M, Reinheimer C, Wichelhaus TA, Kempf VAJ, Kessel J, et al. Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases. Ann Hematol. 2019;98(3):763–73.